SCHEDULE 13D/A

RAPT THERAPEUTICS INC

Common Stock, $0.0001 par value · CUSIP: 75382E109

Event date: 2024-12-23

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares

Unavailable

Percent of class

Unavailable

• The Column Group II, LPReported CIK 0001600420

  Shares: 179,579 · Class: 0.6%

• The Column Group II GP, LPReported CIK 0001645333

  Shares: 179,579 · Class: 0.6%

• Ponoi Capital, LPReported CIK 0001707230

  Shares: 129,579 · Class: 0.4%

• Ponoi Management, LLCReported CIK 0001720702

  Shares: 129,579 · Class: 0.4%

• Ponoi Capital II, LPReported CIK 0001732601

  Shares: 145,401 · Class: 0.5%

• Ponoi II Management, LLCReported CIK 0001746488

  Shares: 145,401 · Class: 0.5%

• The Column Group IV, LPReported CIK 0001796354

  Shares: 1,236,261 · Class: 3.9%

• The Column Group IV-A, LPReported CIK 0001796353

  Shares: 42,189 · Class: 0.1%

• The Column Group IV GP, LPReported CIK 0001796356

  Shares: 1,278,450 · Class: 4%

• The Column Group, LLCReported CIK 0001833486

  Shares: 163 · Class: 0%

• Peter SvennilsonReported CIK 0001606074

  Shares: 1,603,593 · Class: 4.9%

• David V. GoeddelReported CIK 0001182464

  Shares: 1,603,593 · Class: 4.9%

• Tim KutzkeyReported CIK 0001614186

  Shares: 1,553,593 · Class: 4.8%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.